Joshua Zeidner
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Joshua Zeidner
Sep 21, 2024, 10:29 |
Blog
Charlie Craddock: Future trial opportunities in AML
Charlie Craddock, Physician, Queen Elizabeth Hospital shared a post by Joshua Zeidner, Associate Professor Of Medicine,…
Sep 17, 2024, 16:25 |
Blog
Sanam Loghavi: Menin inhibitors in AML—exciting development and combination therapies
Sanam Loghavi posted the following on X: “Menin inhibitors are the most exciting class of…
Aug 12, 2024, 01:35 |
Blog
Joshua Zeidner: Highly impactful data for R/R AML and menin inhibitors
Joshua Zeidner, Associate Professor at UNC Lineberger, shared a post by Ghayas Issa, Leukemia Physician at MD…
Jul 13, 2024, 19:41 |
Insight
Joshua Zeidner: Subset analyses from QUAZAR study
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X about a recent paper by…
Jun 18, 2024, 06:04 |
Opinion
Joshua Zeidner: Important results from ENHANCE-3 by Naval Daver
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X: "Disappointing but important results from…
All:
5
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube